nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—CYP2D6—Gefitinib—lung cancer	0.0549	0.32	CbGbCtD
Pindolol—CYP2D6—Vinorelbine—lung cancer	0.0423	0.246	CbGbCtD
Pindolol—CYP2D6—Erlotinib—lung cancer	0.0325	0.189	CbGbCtD
Pindolol—CYP2D6—Vinblastine—lung cancer	0.0261	0.152	CbGbCtD
Pindolol—CYP2D6—Doxorubicin—lung cancer	0.016	0.0933	CbGbCtD
Pindolol—Nadolol—ABCB1—lung cancer	0.00107	0.19	CrCbGaD
Pindolol—Isoprenaline—CYP1A1—lung cancer	0.00097	0.173	CrCbGaD
Pindolol—Atenolol—ABCB1—lung cancer	0.000933	0.166	CrCbGaD
Pindolol—Acebutolol—ABCB1—lung cancer	0.000861	0.153	CrCbGaD
Pindolol—Loss of consciousness—Paclitaxel—lung cancer	0.000811	0.00121	CcSEcCtD
Pindolol—Hyperhidrosis—Cisplatin—lung cancer	0.000811	0.00121	CcSEcCtD
Pindolol—Mediastinal disorder—Docetaxel—lung cancer	0.00081	0.00121	CcSEcCtD
Pindolol—Paraesthesia—Gemcitabine—lung cancer	0.000808	0.0012	CcSEcCtD
Pindolol—Asthenia—Vinorelbine—lung cancer	0.000804	0.0012	CcSEcCtD
Pindolol—Dyspnoea—Gemcitabine—lung cancer	0.000802	0.00119	CcSEcCtD
Pindolol—Chest pain—Etoposide—lung cancer	0.000802	0.00119	CcSEcCtD
Pindolol—Nausea—Vinblastine—lung cancer	0.000801	0.00119	CcSEcCtD
Pindolol—Somnolence—Gemcitabine—lung cancer	0.0008	0.00119	CcSEcCtD
Pindolol—Gastrointestinal disorder—Irinotecan—lung cancer	0.000798	0.00119	CcSEcCtD
Pindolol—Fatigue—Irinotecan—lung cancer	0.000796	0.00119	CcSEcCtD
Pindolol—Pruritus—Vinorelbine—lung cancer	0.000792	0.00118	CcSEcCtD
Pindolol—Constipation—Irinotecan—lung cancer	0.00079	0.00118	CcSEcCtD
Pindolol—Pain—Irinotecan—lung cancer	0.00079	0.00118	CcSEcCtD
Pindolol—Mental disorder—Docetaxel—lung cancer	0.000787	0.00117	CcSEcCtD
Pindolol—Myalgia—Paclitaxel—lung cancer	0.000786	0.00117	CcSEcCtD
Pindolol—Arthralgia—Paclitaxel—lung cancer	0.000786	0.00117	CcSEcCtD
Pindolol—Chest pain—Paclitaxel—lung cancer	0.000786	0.00117	CcSEcCtD
Pindolol—Hypotension—Cisplatin—lung cancer	0.000784	0.00117	CcSEcCtD
Pindolol—Anxiety—Paclitaxel—lung cancer	0.000783	0.00117	CcSEcCtD
Pindolol—Nausea—Topotecan—lung cancer	0.000778	0.00116	CcSEcCtD
Pindolol—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000777	0.00116	CcSEcCtD
Pindolol—Abdominal discomfort—Methotrexate—lung cancer	0.000776	0.00116	CcSEcCtD
Pindolol—Fatigue—Gemcitabine—lung cancer	0.000776	0.00116	CcSEcCtD
Pindolol—Confusional state—Etoposide—lung cancer	0.000775	0.00115	CcSEcCtD
Pindolol—Pain—Gemcitabine—lung cancer	0.00077	0.00115	CcSEcCtD
Pindolol—Constipation—Gemcitabine—lung cancer	0.00077	0.00115	CcSEcCtD
Pindolol—Nausea—Erlotinib—lung cancer	0.00077	0.00115	CcSEcCtD
Pindolol—Dry mouth—Paclitaxel—lung cancer	0.000769	0.00114	CcSEcCtD
Pindolol—Diarrhoea—Vinorelbine—lung cancer	0.000766	0.00114	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000764	0.00114	CcSEcCtD
Pindolol—Feeling abnormal—Irinotecan—lung cancer	0.000761	0.00113	CcSEcCtD
Pindolol—Confusional state—Paclitaxel—lung cancer	0.00076	0.00113	CcSEcCtD
Pindolol—Gastrointestinal pain—Irinotecan—lung cancer	0.000755	0.00112	CcSEcCtD
Pindolol—Oedema—Paclitaxel—lung cancer	0.000753	0.00112	CcSEcCtD
Pindolol—Paraesthesia—Cisplatin—lung cancer	0.000753	0.00112	CcSEcCtD
Pindolol—Muscle spasms—Docetaxel—lung cancer	0.000752	0.00112	CcSEcCtD
Pindolol—Tachycardia—Etoposide—lung cancer	0.00075	0.00112	CcSEcCtD
Pindolol—Dyspnoea—Cisplatin—lung cancer	0.000748	0.00111	CcSEcCtD
Pindolol—Erectile dysfunction—Methotrexate—lung cancer	0.000745	0.00111	CcSEcCtD
Pindolol—Hyperhidrosis—Etoposide—lung cancer	0.000743	0.00111	CcSEcCtD
Pindolol—Feeling abnormal—Gemcitabine—lung cancer	0.000742	0.0011	CcSEcCtD
Pindolol—Shock—Paclitaxel—lung cancer	0.000741	0.0011	CcSEcCtD
Pindolol—Dizziness—Vinorelbine—lung cancer	0.000741	0.0011	CcSEcCtD
Pindolol—Orthostatic hypotension—Doxorubicin—lung cancer	0.000741	0.0011	CcSEcCtD
Pindolol—Nervous system disorder—Paclitaxel—lung cancer	0.000739	0.0011	CcSEcCtD
Pindolol—Tachycardia—Paclitaxel—lung cancer	0.000735	0.00109	CcSEcCtD
Pindolol—Abdominal pain—Irinotecan—lung cancer	0.00073	0.00109	CcSEcCtD
Pindolol—Hyperhidrosis—Paclitaxel—lung cancer	0.000728	0.00108	CcSEcCtD
Pindolol—Metoprolol—ABCB1—lung cancer	0.000727	0.129	CrCbGaD
Pindolol—Gastrointestinal disorder—Cisplatin—lung cancer	0.000724	0.00108	CcSEcCtD
Pindolol—Drowsiness—Methotrexate—lung cancer	0.000722	0.00107	CcSEcCtD
Pindolol—Depression—Methotrexate—lung cancer	0.00072	0.00107	CcSEcCtD
Pindolol—Hypotension—Etoposide—lung cancer	0.000718	0.00107	CcSEcCtD
Pindolol—Pain—Cisplatin—lung cancer	0.000717	0.00107	CcSEcCtD
Pindolol—Vomiting—Vinorelbine—lung cancer	0.000712	0.00106	CcSEcCtD
Pindolol—Rash—Vinorelbine—lung cancer	0.000706	0.00105	CcSEcCtD
Pindolol—Dermatitis—Vinorelbine—lung cancer	0.000706	0.00105	CcSEcCtD
Pindolol—Hypotension—Paclitaxel—lung cancer	0.000704	0.00105	CcSEcCtD
Pindolol—Headache—Vinorelbine—lung cancer	0.000702	0.00104	CcSEcCtD
Pindolol—Syncope—Docetaxel—lung cancer	0.000702	0.00104	CcSEcCtD
Pindolol—Conjunctivitis—Methotrexate—lung cancer	0.000701	0.00104	CcSEcCtD
Pindolol—Sweating—Methotrexate—lung cancer	0.000692	0.00103	CcSEcCtD
Pindolol—Palpitations—Docetaxel—lung cancer	0.000691	0.00103	CcSEcCtD
Pindolol—Feeling abnormal—Cisplatin—lung cancer	0.000691	0.00103	CcSEcCtD
Pindolol—Propranolol—CYP1A1—lung cancer	0.00069	0.123	CrCbGaD
Pindolol—Paraesthesia—Etoposide—lung cancer	0.00069	0.00103	CcSEcCtD
Pindolol—Loss of consciousness—Docetaxel—lung cancer	0.000688	0.00102	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000686	0.00102	CcSEcCtD
Pindolol—Dyspnoea—Etoposide—lung cancer	0.000685	0.00102	CcSEcCtD
Pindolol—Somnolence—Etoposide—lung cancer	0.000683	0.00102	CcSEcCtD
Pindolol—Insomnia—Paclitaxel—lung cancer	0.000681	0.00101	CcSEcCtD
Pindolol—Paraesthesia—Paclitaxel—lung cancer	0.000677	0.00101	CcSEcCtD
Pindolol—Dyspnoea—Paclitaxel—lung cancer	0.000672	0.001	CcSEcCtD
Pindolol—Somnolence—Paclitaxel—lung cancer	0.00067	0.000997	CcSEcCtD
Pindolol—Myalgia—Docetaxel—lung cancer	0.000666	0.000992	CcSEcCtD
Pindolol—Chest pain—Docetaxel—lung cancer	0.000666	0.000992	CcSEcCtD
Pindolol—Arthralgia—Docetaxel—lung cancer	0.000666	0.000992	CcSEcCtD
Pindolol—Nausea—Vinorelbine—lung cancer	0.000665	0.000991	CcSEcCtD
Pindolol—Gastrointestinal disorder—Etoposide—lung cancer	0.000663	0.000988	CcSEcCtD
Pindolol—Dyspepsia—Paclitaxel—lung cancer	0.000663	0.000987	CcSEcCtD
Pindolol—Asthenia—Irinotecan—lung cancer	0.000663	0.000987	CcSEcCtD
Pindolol—Fatigue—Etoposide—lung cancer	0.000662	0.000986	CcSEcCtD
Pindolol—Pain—Etoposide—lung cancer	0.000657	0.000978	CcSEcCtD
Pindolol—Constipation—Etoposide—lung cancer	0.000657	0.000978	CcSEcCtD
Pindolol—Dry mouth—Docetaxel—lung cancer	0.000652	0.00097	CcSEcCtD
Pindolol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00065	0.000968	CcSEcCtD
Pindolol—Fatigue—Paclitaxel—lung cancer	0.00065	0.000967	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—lung cancer	0.000647	0.000964	CcSEcCtD
Pindolol—Asthenia—Gemcitabine—lung cancer	0.000646	0.000961	CcSEcCtD
Pindolol—Constipation—Paclitaxel—lung cancer	0.000644	0.000959	CcSEcCtD
Pindolol—Pain—Paclitaxel—lung cancer	0.000644	0.000959	CcSEcCtD
Pindolol—Confusional state—Docetaxel—lung cancer	0.000644	0.000959	CcSEcCtD
Pindolol—Oedema—Docetaxel—lung cancer	0.000639	0.000951	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—lung cancer	0.000638	0.00095	CcSEcCtD
Pindolol—Pruritus—Gemcitabine—lung cancer	0.000637	0.000948	CcSEcCtD
Pindolol—Feeling abnormal—Etoposide—lung cancer	0.000633	0.000943	CcSEcCtD
Pindolol—Diarrhoea—Irinotecan—lung cancer	0.000632	0.000941	CcSEcCtD
Pindolol—Gastrointestinal pain—Etoposide—lung cancer	0.000628	0.000936	CcSEcCtD
Pindolol—Shock—Docetaxel—lung cancer	0.000628	0.000935	CcSEcCtD
Pindolol—Nervous system disorder—Docetaxel—lung cancer	0.000626	0.000932	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—lung cancer	0.000625	0.00093	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—lung cancer	0.000624	0.00093	CcSEcCtD
Pindolol—Tachycardia—Docetaxel—lung cancer	0.000623	0.000928	CcSEcCtD
Pindolol—Feeling abnormal—Paclitaxel—lung cancer	0.000621	0.000924	CcSEcCtD
Pindolol—Gastrointestinal pain—Paclitaxel—lung cancer	0.000616	0.000917	CcSEcCtD
Pindolol—Diarrhoea—Gemcitabine—lung cancer	0.000616	0.000917	CcSEcCtD
Pindolol—Dizziness—Irinotecan—lung cancer	0.000611	0.00091	CcSEcCtD
Pindolol—Abdominal pain—Etoposide—lung cancer	0.000607	0.000904	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—lung cancer	0.000607	0.000904	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—lung cancer	0.000604	0.000899	CcSEcCtD
Pindolol—Asthenia—Cisplatin—lung cancer	0.000602	0.000896	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—lung cancer	0.000601	0.000895	CcSEcCtD
Pindolol—Sweating—Doxorubicin—lung cancer	0.000599	0.000892	CcSEcCtD
Pindolol—Hypotension—Docetaxel—lung cancer	0.000597	0.000888	CcSEcCtD
Pindolol—Abdominal pain—Paclitaxel—lung cancer	0.000596	0.000887	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—lung cancer	0.000588	0.000875	CcSEcCtD
Pindolol—Vomiting—Irinotecan—lung cancer	0.000587	0.000875	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—lung cancer	0.000584	0.000869	CcSEcCtD
Pindolol—Rash—Irinotecan—lung cancer	0.000582	0.000867	CcSEcCtD
Pindolol—Dermatitis—Irinotecan—lung cancer	0.000582	0.000866	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000582	0.000866	CcSEcCtD
Pindolol—Headache—Irinotecan—lung cancer	0.000579	0.000862	CcSEcCtD
Pindolol—Insomnia—Docetaxel—lung cancer	0.000578	0.00086	CcSEcCtD
Pindolol—Diarrhoea—Cisplatin—lung cancer	0.000574	0.000854	CcSEcCtD
Pindolol—Paraesthesia—Docetaxel—lung cancer	0.000573	0.000854	CcSEcCtD
Pindolol—Vomiting—Gemcitabine—lung cancer	0.000572	0.000852	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—lung cancer	0.000571	0.00085	CcSEcCtD
Pindolol—Dyspnoea—Docetaxel—lung cancer	0.000569	0.000848	CcSEcCtD
Pindolol—Somnolence—Docetaxel—lung cancer	0.000568	0.000845	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—lung cancer	0.000568	0.000845	CcSEcCtD
Pindolol—Rash—Gemcitabine—lung cancer	0.000567	0.000845	CcSEcCtD
Pindolol—Dermatitis—Gemcitabine—lung cancer	0.000567	0.000844	CcSEcCtD
Pindolol—Headache—Gemcitabine—lung cancer	0.000564	0.000839	CcSEcCtD
Pindolol—Dyspepsia—Docetaxel—lung cancer	0.000562	0.000837	CcSEcCtD
Pindolol—Gastrointestinal disorder—Docetaxel—lung cancer	0.000551	0.000821	CcSEcCtD
Pindolol—Asthenia—Etoposide—lung cancer	0.000551	0.000821	CcSEcCtD
Pindolol—Fatigue—Docetaxel—lung cancer	0.000551	0.00082	CcSEcCtD
Pindolol—Nausea—Irinotecan—lung cancer	0.000549	0.000817	CcSEcCtD
Pindolol—Pain—Docetaxel—lung cancer	0.000546	0.000813	CcSEcCtD
Pindolol—Constipation—Docetaxel—lung cancer	0.000546	0.000813	CcSEcCtD
Pindolol—Pruritus—Etoposide—lung cancer	0.000544	0.000809	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—lung cancer	0.000541	0.000805	CcSEcCtD
Pindolol—Asthenia—Paclitaxel—lung cancer	0.000541	0.000805	CcSEcCtD
Pindolol—Nausea—Gemcitabine—lung cancer	0.000535	0.000796	CcSEcCtD
Pindolol—Vomiting—Cisplatin—lung cancer	0.000533	0.000794	CcSEcCtD
Pindolol—Pruritus—Paclitaxel—lung cancer	0.000533	0.000794	CcSEcCtD
Pindolol—Rash—Cisplatin—lung cancer	0.000529	0.000787	CcSEcCtD
Pindolol—Dermatitis—Cisplatin—lung cancer	0.000528	0.000787	CcSEcCtD
Pindolol—Feeling abnormal—Docetaxel—lung cancer	0.000526	0.000784	CcSEcCtD
Pindolol—Diarrhoea—Etoposide—lung cancer	0.000526	0.000783	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—lung cancer	0.000523	0.000779	CcSEcCtD
Pindolol—Gastrointestinal pain—Docetaxel—lung cancer	0.000522	0.000778	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—lung cancer	0.000521	0.000775	CcSEcCtD
Pindolol—Diarrhoea—Paclitaxel—lung cancer	0.000515	0.000768	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—lung cancer	0.000509	0.000758	CcSEcCtD
Pindolol—Dizziness—Etoposide—lung cancer	0.000508	0.000757	CcSEcCtD
Pindolol—Vertigo—Methotrexate—lung cancer	0.000507	0.000754	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—lung cancer	0.000506	0.000753	CcSEcCtD
Pindolol—Abdominal pain—Docetaxel—lung cancer	0.000505	0.000752	CcSEcCtD
Pindolol—Dizziness—Paclitaxel—lung cancer	0.000498	0.000742	CcSEcCtD
Pindolol—Nausea—Cisplatin—lung cancer	0.000498	0.000742	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—lung cancer	0.000491	0.000732	CcSEcCtD
Pindolol—Vomiting—Etoposide—lung cancer	0.000489	0.000727	CcSEcCtD
Pindolol—Rash—Etoposide—lung cancer	0.000484	0.000721	CcSEcCtD
Pindolol—Dermatitis—Etoposide—lung cancer	0.000484	0.000721	CcSEcCtD
Pindolol—Headache—Etoposide—lung cancer	0.000481	0.000717	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—lung cancer	0.000481	0.000716	CcSEcCtD
Pindolol—Chest pain—Methotrexate—lung cancer	0.00048	0.000715	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—lung cancer	0.00048	0.000715	CcSEcCtD
Pindolol—Myalgia—Methotrexate—lung cancer	0.00048	0.000715	CcSEcCtD
Pindolol—Tension—Doxorubicin—lung cancer	0.000479	0.000714	CcSEcCtD
Pindolol—Vomiting—Paclitaxel—lung cancer	0.000479	0.000713	CcSEcCtD
Pindolol—Rash—Paclitaxel—lung cancer	0.000475	0.000707	CcSEcCtD
Pindolol—Dermatitis—Paclitaxel—lung cancer	0.000475	0.000707	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—lung cancer	0.000474	0.000706	CcSEcCtD
Pindolol—Headache—Paclitaxel—lung cancer	0.000472	0.000703	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—lung cancer	0.00047	0.000699	CcSEcCtD
Pindolol—Confusional state—Methotrexate—lung cancer	0.000464	0.000691	CcSEcCtD
Pindolol—Asthenia—Docetaxel—lung cancer	0.000458	0.000682	CcSEcCtD
Pindolol—Nausea—Etoposide—lung cancer	0.000456	0.00068	CcSEcCtD
Pindolol—Pruritus—Docetaxel—lung cancer	0.000452	0.000673	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—lung cancer	0.000451	0.000672	CcSEcCtD
Pindolol—Nausea—Paclitaxel—lung cancer	0.000448	0.000666	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—lung cancer	0.000445	0.000663	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—lung cancer	0.000439	0.000653	CcSEcCtD
Pindolol—Syncope—Doxorubicin—lung cancer	0.000438	0.000652	CcSEcCtD
Pindolol—Diarrhoea—Docetaxel—lung cancer	0.000437	0.000651	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—lung cancer	0.000432	0.000643	CcSEcCtD
Pindolol—Hypotension—Methotrexate—lung cancer	0.00043	0.00064	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—lung cancer	0.000429	0.000639	CcSEcCtD
Pindolol—Dizziness—Docetaxel—lung cancer	0.000422	0.000629	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000419	0.000624	CcSEcCtD
Pindolol—Insomnia—Methotrexate—lung cancer	0.000416	0.00062	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—lung cancer	0.000416	0.000619	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—lung cancer	0.000416	0.000619	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—lung cancer	0.000416	0.000619	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—lung cancer	0.000414	0.000617	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—lung cancer	0.000413	0.000615	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—lung cancer	0.00041	0.000611	CcSEcCtD
Pindolol—Somnolence—Methotrexate—lung cancer	0.000409	0.000609	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—lung cancer	0.000407	0.000605	CcSEcCtD
Pindolol—Vomiting—Docetaxel—lung cancer	0.000406	0.000605	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—lung cancer	0.000405	0.000603	CcSEcCtD
Pindolol—Rash—Docetaxel—lung cancer	0.000403	0.0006	CcSEcCtD
Pindolol—Dermatitis—Docetaxel—lung cancer	0.000402	0.000599	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—lung cancer	0.000402	0.000598	CcSEcCtD
Pindolol—Headache—Docetaxel—lung cancer	0.0004	0.000596	CcSEcCtD
Pindolol—Oedema—Doxorubicin—lung cancer	0.000399	0.000593	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—lung cancer	0.000397	0.000592	CcSEcCtD
Pindolol—Fatigue—Methotrexate—lung cancer	0.000397	0.000591	CcSEcCtD
Pindolol—Pain—Methotrexate—lung cancer	0.000394	0.000586	CcSEcCtD
Pindolol—Shock—Doxorubicin—lung cancer	0.000392	0.000584	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—lung cancer	0.000391	0.000582	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—lung cancer	0.000389	0.000579	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—lung cancer	0.000385	0.000574	CcSEcCtD
Pindolol—Nausea—Docetaxel—lung cancer	0.000379	0.000565	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—lung cancer	0.000379	0.000565	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—lung cancer	0.000376	0.00056	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—lung cancer	0.000372	0.000555	CcSEcCtD
Pindolol—Propranolol—ABCB1—lung cancer	0.000367	0.0653	CrCbGaD
Pindolol—Abdominal pain—Methotrexate—lung cancer	0.000364	0.000542	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000363	0.000541	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—lung cancer	0.00036	0.000537	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—lung cancer	0.000358	0.000533	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—lung cancer	0.000355	0.000529	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—lung cancer	0.000354	0.000528	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—lung cancer	0.000351	0.000522	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000344	0.000512	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—lung cancer	0.000344	0.000512	CcSEcCtD
Pindolol—Pain—Doxorubicin—lung cancer	0.000341	0.000507	CcSEcCtD
Pindolol—Constipation—Doxorubicin—lung cancer	0.000341	0.000507	CcSEcCtD
Pindolol—Asthenia—Methotrexate—lung cancer	0.00033	0.000492	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—lung cancer	0.000328	0.000489	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—lung cancer	0.000326	0.000485	CcSEcCtD
Pindolol—Pruritus—Methotrexate—lung cancer	0.000326	0.000485	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—lung cancer	0.000315	0.000469	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—lung cancer	0.000315	0.000469	CcSEcCtD
Pindolol—Dizziness—Methotrexate—lung cancer	0.000304	0.000453	CcSEcCtD
Pindolol—Vomiting—Methotrexate—lung cancer	0.000293	0.000436	CcSEcCtD
Pindolol—Rash—Methotrexate—lung cancer	0.00029	0.000432	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—lung cancer	0.00029	0.000432	CcSEcCtD
Pindolol—Headache—Methotrexate—lung cancer	0.000288	0.000429	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—lung cancer	0.000286	0.000426	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—lung cancer	0.000282	0.00042	CcSEcCtD
Pindolol—Nausea—Methotrexate—lung cancer	0.000273	0.000407	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—lung cancer	0.000273	0.000406	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—lung cancer	0.000264	0.000392	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—lung cancer	0.000253	0.000377	CcSEcCtD
Pindolol—Rash—Doxorubicin—lung cancer	0.000251	0.000374	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—lung cancer	0.000251	0.000374	CcSEcCtD
Pindolol—Headache—Doxorubicin—lung cancer	0.00025	0.000372	CcSEcCtD
Pindolol—Nausea—Doxorubicin—lung cancer	0.000237	0.000352	CcSEcCtD
Pindolol—HTR1B—Signaling by GPCR—MAPK3—lung cancer	3.67e-05	0.000243	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AKT1—lung cancer	3.66e-05	0.000242	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—POMC—lung cancer	3.65e-05	0.000241	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCL8—lung cancer	3.64e-05	0.000241	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL2—lung cancer	3.64e-05	0.000241	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CASP3—lung cancer	3.62e-05	0.00024	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TERT—lung cancer	3.62e-05	0.00024	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL2—lung cancer	3.62e-05	0.00024	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ERBB3—lung cancer	3.62e-05	0.000239	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—BRAF—lung cancer	3.6e-05	0.000238	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—IL6—lung cancer	3.6e-05	0.000238	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6R—lung cancer	3.56e-05	0.000236	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL2—lung cancer	3.56e-05	0.000235	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CREBBP—lung cancer	3.55e-05	0.000235	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TERT—lung cancer	3.54e-05	0.000235	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ENO1—lung cancer	3.54e-05	0.000235	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCND1—lung cancer	3.53e-05	0.000234	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—JUN—lung cancer	3.52e-05	0.000233	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	3.52e-05	0.000233	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—lung cancer	3.49e-05	0.000231	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL2—lung cancer	3.48e-05	0.00023	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TERT—lung cancer	3.47e-05	0.000229	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	3.46e-05	0.000229	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	3.44e-05	0.000228	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—lung cancer	3.42e-05	0.000227	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CDKN1A—lung cancer	3.41e-05	0.000226	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PTEN—lung cancer	3.4e-05	0.000225	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAP2K1—lung cancer	3.39e-05	0.000225	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	3.39e-05	0.000224	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CD—lung cancer	3.37e-05	0.000223	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FGFR1—lung cancer	3.36e-05	0.000223	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOA1—lung cancer	3.34e-05	0.000221	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PIK3CA—lung cancer	3.34e-05	0.000221	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—lung cancer	3.32e-05	0.00022	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HIF1A—lung cancer	3.31e-05	0.000219	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KDR—lung cancer	3.31e-05	0.000219	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—KRAS—lung cancer	3.3e-05	0.000218	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOA1—lung cancer	3.27e-05	0.000216	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EP300—lung cancer	3.25e-05	0.000215	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KDR—lung cancer	3.24e-05	0.000215	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOA1—lung cancer	3.2e-05	0.000212	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP2E1—lung cancer	3.18e-05	0.00021	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KDR—lung cancer	3.17e-05	0.00021	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SRC—lung cancer	3.16e-05	0.000209	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NQO1—lung cancer	3.14e-05	0.000208	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—lung cancer	3.08e-05	0.000204	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	3.05e-05	0.000202	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KIT—lung cancer	3.05e-05	0.000202	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APC—lung cancer	3.05e-05	0.000202	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	3.05e-05	0.000202	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STAT3—lung cancer	3.05e-05	0.000202	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NRAS—lung cancer	3.04e-05	0.000201	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CA—lung cancer	3.03e-05	0.000201	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MDM2—lung cancer	3.02e-05	0.0002	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGF—lung cancer	3.02e-05	0.0002	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RAF1—lung cancer	3.01e-05	0.000199	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	2.99e-05	0.000198	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APC—lung cancer	2.99e-05	0.000198	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KIT—lung cancer	2.99e-05	0.000198	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	2.99e-05	0.000198	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ERBB2—lung cancer	2.98e-05	0.000197	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGF—lung cancer	2.95e-05	0.000195	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MTOR—lung cancer	2.94e-05	0.000194	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CB—lung cancer	2.94e-05	0.000194	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	2.92e-05	0.000194	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APC—lung cancer	2.92e-05	0.000193	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CG—lung cancer	2.92e-05	0.000193	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KIT—lung cancer	2.92e-05	0.000193	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—NRAS—lung cancer	2.92e-05	0.000193	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK3—lung cancer	2.91e-05	0.000193	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—POMC—lung cancer	2.91e-05	0.000192	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGF—lung cancer	2.89e-05	0.000191	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—BRAF—lung cancer	2.87e-05	0.00019	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	2.86e-05	0.000189	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—POMC—lung cancer	2.84e-05	0.000188	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6R—lung cancer	2.83e-05	0.000188	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—STK11—lung cancer	2.83e-05	0.000187	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	2.83e-05	0.000187	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MYC—lung cancer	2.83e-05	0.000187	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL8—lung cancer	2.82e-05	0.000187	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—BRAF—lung cancer	2.81e-05	0.000186	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HRAS—lung cancer	2.8e-05	0.000186	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—MAPK3—lung cancer	2.8e-05	0.000185	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	2.78e-05	0.000184	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—POMC—lung cancer	2.78e-05	0.000184	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6R—lung cancer	2.77e-05	0.000184	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	2.77e-05	0.000183	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—lung cancer	2.77e-05	0.000183	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—BRAF—lung cancer	2.74e-05	0.000182	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—lung cancer	2.73e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	2.72e-05	0.00018	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6R—lung cancer	2.71e-05	0.000179	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CREBBP—lung cancer	2.71e-05	0.000179	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	2.7e-05	0.000179	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CASP3—lung cancer	2.7e-05	0.000179	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL2—lung cancer	2.7e-05	0.000179	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—lung cancer	2.68e-05	0.000178	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	2.68e-05	0.000178	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—lung cancer	2.66e-05	0.000176	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	2.66e-05	0.000176	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	2.64e-05	0.000175	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—lung cancer	2.63e-05	0.000174	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	2.63e-05	0.000174	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	2.62e-05	0.000174	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—JUN—lung cancer	2.62e-05	0.000174	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTP1—lung cancer	2.62e-05	0.000173	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KRAS—lung cancer	2.61e-05	0.000173	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	2.6e-05	0.000172	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAP2K1—lung cancer	2.58e-05	0.000171	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	2.57e-05	0.00017	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CD—lung cancer	2.57e-05	0.00017	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—lung cancer	2.55e-05	0.000169	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CAT—lung cancer	2.55e-05	0.000169	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1A—lung cancer	2.54e-05	0.000168	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	2.54e-05	0.000168	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PTEN—lung cancer	2.54e-05	0.000168	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—KRAS—lung cancer	2.51e-05	0.000166	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCB1—lung cancer	2.48e-05	0.000164	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—lung cancer	2.48e-05	0.000164	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TYMS—lung cancer	2.44e-05	0.000161	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EP300—lung cancer	2.42e-05	0.00016	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	2.41e-05	0.00016	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—lung cancer	2.41e-05	0.000159	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MDM2—lung cancer	2.4e-05	0.000159	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CA—lung cancer	2.4e-05	0.000159	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RAF1—lung cancer	2.4e-05	0.000159	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	2.37e-05	0.000157	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	2.36e-05	0.000156	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SRC—lung cancer	2.35e-05	0.000156	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MDM2—lung cancer	2.35e-05	0.000156	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RAF1—lung cancer	2.34e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MTOR—lung cancer	2.34e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	2.34e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—lung cancer	2.32e-05	0.000154	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	2.32e-05	0.000153	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	2.31e-05	0.000153	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MDM2—lung cancer	2.3e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—lung cancer	2.29e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RAF1—lung cancer	2.29e-05	0.000152	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MTOR—lung cancer	2.29e-05	0.000151	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	2.29e-05	0.000151	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1A1—lung cancer	2.28e-05	0.000151	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STAT3—lung cancer	2.27e-05	0.00015	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ERBB2—lung cancer	2.27e-05	0.00015	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ERCC2—lung cancer	2.26e-05	0.00015	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NRAS—lung cancer	2.26e-05	0.00015	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	2.25e-05	0.000149	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MTOR—lung cancer	2.24e-05	0.000148	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CB—lung cancer	2.24e-05	0.000148	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	2.23e-05	0.000148	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HRAS—lung cancer	2.22e-05	0.000147	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	2.2e-05	0.000146	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	2.18e-05	0.000145	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	2.17e-05	0.000144	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK3—lung cancer	2.17e-05	0.000144	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CASP3—lung cancer	2.15e-05	0.000142	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL8—lung cancer	2.15e-05	0.000142	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL2—lung cancer	2.15e-05	0.000142	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—lung cancer	2.14e-05	0.000141	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HRAS—lung cancer	2.14e-05	0.000141	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—lung cancer	2.13e-05	0.000141	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	2.12e-05	0.000141	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MYC—lung cancer	2.11e-05	0.00014	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CASP3—lung cancer	2.1e-05	0.000139	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL2—lung cancer	2.1e-05	0.000139	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—lung cancer	2.09e-05	0.000139	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—lung cancer	2.09e-05	0.000138	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JUN—lung cancer	2.09e-05	0.000138	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—lung cancer	2.08e-05	0.000137	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—lung cancer	2.06e-05	0.000137	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CASP3—lung cancer	2.06e-05	0.000136	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL2—lung cancer	2.05e-05	0.000136	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—lung cancer	2.05e-05	0.000136	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—lung cancer	2.04e-05	0.000135	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JUN—lung cancer	2.04e-05	0.000135	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—lung cancer	2.03e-05	0.000135	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	2.03e-05	0.000134	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTEN—lung cancer	2.02e-05	0.000134	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—lung cancer	2e-05	0.000133	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JUN—lung cancer	2e-05	0.000132	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—lung cancer	1.99e-05	0.000132	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	1.98e-05	0.000131	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTEN—lung cancer	1.98e-05	0.000131	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	1.97e-05	0.000131	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—lung cancer	1.96e-05	0.00013	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOA1—lung cancer	1.96e-05	0.00013	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KRAS—lung cancer	1.95e-05	0.000129	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—lung cancer	1.94e-05	0.000129	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1A—lung cancer	1.94e-05	0.000128	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTEN—lung cancer	1.93e-05	0.000128	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	1.93e-05	0.000128	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EP300—lung cancer	1.93e-05	0.000128	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.89e-05	0.000125	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EP300—lung cancer	1.89e-05	0.000125	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SRC—lung cancer	1.87e-05	0.000124	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EP300—lung cancer	1.84e-05	0.000122	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SRC—lung cancer	1.83e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	1.83e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STAT3—lung cancer	1.81e-05	0.00012	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NRAS—lung cancer	1.8e-05	0.000119	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SRC—lung cancer	1.79e-05	0.000119	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CA—lung cancer	1.79e-05	0.000119	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CG—lung cancer	1.79e-05	0.000118	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	1.79e-05	0.000118	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STAT3—lung cancer	1.77e-05	0.000117	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NRAS—lung cancer	1.76e-05	0.000117	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.75e-05	0.000116	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—lung cancer	1.73e-05	0.000115	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STAT3—lung cancer	1.73e-05	0.000114	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	1.73e-05	0.000114	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NRAS—lung cancer	1.72e-05	0.000114	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—POMC—lung cancer	1.7e-05	0.000113	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.69e-05	0.000112	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MYC—lung cancer	1.68e-05	0.000111	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CREBBP—lung cancer	1.66e-05	0.00011	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HRAS—lung cancer	1.66e-05	0.00011	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.65e-05	0.000109	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MYC—lung cancer	1.64e-05	0.000109	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—lung cancer	1.64e-05	0.000109	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—lung cancer	1.61e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MYC—lung cancer	1.61e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—lung cancer	1.59e-05	0.000105	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CD—lung cancer	1.57e-05	0.000104	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—lung cancer	1.57e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KRAS—lung cancer	1.55e-05	0.000103	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—lung cancer	1.55e-05	0.000103	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KRAS—lung cancer	1.52e-05	0.0001	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KRAS—lung cancer	1.48e-05	9.83e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—lung cancer	1.46e-05	9.68e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.43e-05	9.44e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.39e-05	9.23e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—lung cancer	1.38e-05	9.13e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CB—lung cancer	1.37e-05	9.07e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.36e-05	9.03e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—lung cancer	1.36e-05	8.99e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—lung cancer	1.35e-05	8.93e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—lung cancer	1.32e-05	8.73e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HRAS—lung cancer	1.32e-05	8.73e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HRAS—lung cancer	1.29e-05	8.54e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—lung cancer	1.26e-05	8.36e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HRAS—lung cancer	1.26e-05	8.35e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—lung cancer	1.23e-05	8.18e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—lung cancer	1.21e-05	7.99e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTEN—lung cancer	1.18e-05	7.84e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—lung cancer	1.16e-05	7.71e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—lung cancer	1.14e-05	7.54e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—EP300—lung cancer	1.13e-05	7.47e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—lung cancer	1.11e-05	7.37e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CA—lung cancer	8.35e-06	5.53e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—lung cancer	6.82e-06	4.52e-05	CbGpPWpGaD
